Syros Pharmaceuticals Inc (NASDAQ:SYRS)
| 4.44 Delayed Data As of 3:59pm ET |  0.00 / 0.00%Today’s Change | 3.02 Today|||52-Week Range 22.70 | +23.68% Year-to-Date |
Latest SYRS News | Press Releases
No recent news for Syros Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.44 |
| Today’s open | 4.57 |
| Day’s range | 4.09 - 4.63 |
| Volume | 16,440 |
| Average volume (3 months) | 174,337 |
| Market cap | $65.9M |
Data as of 3:59pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | +24.15% |
| Earnings growth (this year) | +32.13% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +55.62% |
| P/E ratio | NM |
| Price/Sales | 8.68 |
| Price/Book | 0.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRTGPortage Biotech Inc | 0.00 | 0.00% |
| FIXXHomology Medicines I... | -0.02 | -1.28% |
| SEELSeelos Therapeutics ... | 0.00 | 0.00% |
| CODXCo-Diagnostics Inc | +0.02 | +0.71% |
Data as of 3:59pm ET, 01/26/2023
Financials
| Next reporting date | March 14, 2023 |
| EPS forecast (this quarter) | -$1.23 |
| Annual revenue (last year) | $23.5M |
| Annual profit (last year) | -$86.6M |
| Net profit margin | -368.52% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
